A second experimental vaccine against the Ebola virus is to be introduced in the Democratic Republic of Congo, which is currently experiencing the world’s second-largest Ebola outbreak on record, with more than 2,000 lives lost and some 3,000 infections confirmed since the latest epidemic was declared in August last year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?